133 related articles for article (PubMed ID: 37422538)
1. DNAJC9 expression in basal-like and luminal A breast cancer subtypes predicts worse survival.
Incekara O; Acun T
Mol Biol Rep; 2023 Sep; 50(9):7275-7282. PubMed ID: 37422538
[TBL] [Abstract][Full Text] [Related]
2. High expression of
Ileri FC; Acun T
Biomark Med; 2021 Aug; 15(12):941-950. PubMed ID: 34236236
[No Abstract] [Full Text] [Related]
3. Downregulation of DNAJC10 (ERDJ5) is associated with poor survival in breast cancer.
Acun T; Senses KM
Breast Cancer; 2020 May; 27(3):483-489. PubMed ID: 31902119
[TBL] [Abstract][Full Text] [Related]
4. Molecular subtypes of breast cancer are associated with characteristic DNA methylation patterns.
Holm K; Hegardt C; Staaf J; Vallon-Christersson J; Jönsson G; Olsson H; Borg A; Ringnér M
Breast Cancer Res; 2010; 12(3):R36. PubMed ID: 20565864
[TBL] [Abstract][Full Text] [Related]
5. An integrated genomics analysis of epigenetic subtypes in human breast tumors links DNA methylation patterns to chromatin states in normal mammary cells.
Holm K; Staaf J; Lauss M; Aine M; Lindgren D; Bendahl PO; Vallon-Christersson J; Barkardottir RB; Höglund M; Borg Å; Jönsson G; Ringnér M
Breast Cancer Res; 2016 Feb; 18(1):27. PubMed ID: 26923702
[TBL] [Abstract][Full Text] [Related]
6. Subtype-specific overexpression of the Rac-GEF P-REX1 in breast cancer is associated with promoter hypomethylation.
Barrio-Real L; Benedetti LG; Engel N; Tu Y; Cho S; Sukumar S; Kazanietz MG
Breast Cancer Res; 2014 Sep; 16(5):441. PubMed ID: 25248717
[TBL] [Abstract][Full Text] [Related]
7. Expression and methylation patterns partition luminal-A breast tumors into distinct prognostic subgroups.
Netanely D; Avraham A; Ben-Baruch A; Evron E; Shamir R
Breast Cancer Res; 2016 Jul; 18(1):74. PubMed ID: 27386846
[TBL] [Abstract][Full Text] [Related]
8. Basal-like breast cancer displays distinct patterns of promoter methylation.
Lee JS; Fackler MJ; Lee JH; Choi C; Park MH; Yoon JH; Zhang Z; Sukumar S
Cancer Biol Ther; 2010 Jun; 9(12):1017-24. PubMed ID: 20505321
[TBL] [Abstract][Full Text] [Related]
9. Distinct patterns of promoter CpG island methylation of breast cancer subtypes are associated with stem cell phenotypes.
Park SY; Kwon HJ; Choi Y; Lee HE; Kim SW; Kim JH; Kim IA; Jung N; Cho NY; Kang GH
Mod Pathol; 2012 Feb; 25(2):185-96. PubMed ID: 22037257
[TBL] [Abstract][Full Text] [Related]
10. MGP is downregulated due to promoter methylation in chemoresistant ER+ breast cancer and high MGP expression predicts better survival outcomes.
Tuo YL; Ye YF
Eur Rev Med Pharmacol Sci; 2017 Oct; 21(17):3871-3878. PubMed ID: 28975977
[TBL] [Abstract][Full Text] [Related]
11. DNA methylation epigenotypes in breast cancer molecular subtypes.
Bediaga NG; Acha-Sagredo A; Guerra I; Viguri A; Albaina C; Ruiz Diaz I; Rezola R; Alberdi MJ; Dopazo J; Montaner D; Renobales M; Fernández AF; Field JK; Fraga MF; Liloglou T; de Pancorbo MM
Breast Cancer Res; 2010; 12(5):R77. PubMed ID: 20920229
[TBL] [Abstract][Full Text] [Related]
12. Molecular profiling of breast cancer cell lines defines relevant tumor models and provides a resource for cancer gene discovery.
Kao J; Salari K; Bocanegra M; Choi YL; Girard L; Gandhi J; Kwei KA; Hernandez-Boussard T; Wang P; Gazdar AF; Minna JD; Pollack JR
PLoS One; 2009 Jul; 4(7):e6146. PubMed ID: 19582160
[TBL] [Abstract][Full Text] [Related]
13. Investigation of genes and pathways involved in breast cancer subtypes through gene expression meta-analysis.
Jafarinejad-Farsangi S; Moazzam-Jazi M; Naderi Ghale-Noie Z; Askari N; Miri Karam Z; Mollazadeh S; Hadizadeh M
Gene; 2022 May; 821():146328. PubMed ID: 35181505
[TBL] [Abstract][Full Text] [Related]
14. Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study.
Carey LA; Perou CM; Livasy CA; Dressler LG; Cowan D; Conway K; Karaca G; Troester MA; Tse CK; Edmiston S; Deming SL; Geradts J; Cheang MC; Nielsen TO; Moorman PG; Earp HS; Millikan RC
JAMA; 2006 Jun; 295(21):2492-502. PubMed ID: 16757721
[TBL] [Abstract][Full Text] [Related]
15. Phenotypic evaluation of the basal-like subtype of invasive breast carcinoma.
Livasy CA; Karaca G; Nanda R; Tretiakova MS; Olopade OI; Moore DT; Perou CM
Mod Pathol; 2006 Feb; 19(2):264-71. PubMed ID: 16341146
[TBL] [Abstract][Full Text] [Related]
16. Breast cancer subtyping from plasma proteins.
Zhang F; Chen JY
BMC Med Genomics; 2013; 6 Suppl 1(Suppl 1):S6. PubMed ID: 23369492
[TBL] [Abstract][Full Text] [Related]
17. Vimentin DNA methylation predicts survival in breast cancer.
Ulirsch J; Fan C; Knafl G; Wu MJ; Coleman B; Perou CM; Swift-Scanlan T
Breast Cancer Res Treat; 2013 Jan; 137(2):383-96. PubMed ID: 23239149
[TBL] [Abstract][Full Text] [Related]
18. Association of poor prognosis subtypes of breast cancer with estrogen receptor alpha methylation in Iranian women.
Izadi P; Mehrdad N; Foruzandeh F; Reza NM
Asian Pac J Cancer Prev; 2012; 13(8):4113-7. PubMed ID: 23098526
[TBL] [Abstract][Full Text] [Related]
19. miRNA expression profiling of 51 human breast cancer cell lines reveals subtype and driver mutation-specific miRNAs.
Riaz M; van Jaarsveld MT; Hollestelle A; Prager-van der Smissen WJ; Heine AA; Boersma AW; Liu J; Helmijr J; Ozturk B; Smid M; Wiemer EA; Foekens JA; Martens JW
Breast Cancer Res; 2013 Apr; 15(2):R33. PubMed ID: 23601657
[TBL] [Abstract][Full Text] [Related]
20. Molecular breast cancer subtypes in premenopausal and postmenopausal African-American women: age-specific prevalence and survival.
Ihemelandu CU; Leffall LD; Dewitty RL; Naab TJ; Mezghebe HM; Makambi KH; Adams-Campbell L; Frederick WA
J Surg Res; 2007 Nov; 143(1):109-18. PubMed ID: 17950079
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
